Skip to content
The Nexus
DossierENTITY

genomic testing

Coverage of genomic testing in the Nexus archive.

Earliest in view: Jul 1 · 18:28 UTCMost recent: Jul 1 · 18:28 UTC
Co-mentioned in this coverage
OPTIMA trialtopic1American Society of Clinical Oncologyorganization1hormone receptor-positive/HER2-negative early breast cancertopic1chemotherapytopic1
Recent coverage
  • HEALTHJul 1 · 18:28 UTCMEDPAGE TODAY
    More Early Breast Cancer Patients Could Be Spared Chemo, Trial Suggests

    The OPTIMA trial suggests genomic testing could identify more hormone receptor-positive/HER2-negative early breast cancer patients who might avoid chemotherapy. Results were presented at the American Society of Clinical Oncology (ASCO) meeting.